Related by context. All words. (Click for frequent words.) 73 elotuzumab 73 phase IIb clinical 73 YONDELIS 73 Plicera 73 Raptiva ® 72 Troxatyl 72 TELINTRA 72 Dacogen decitabine 72 TRISENOX 71 sunitinib malate 71 interferon gamma 1b 71 Velcade bortezomib 71 Clolar ® 71 ularitide 71 OvaRex ® MAb 71 HuMax CD4 71 SinuNase TM 71 Actimmune ® 71 Phase IIb clinical trials 71 Ixempra 71 Amigal 71 Phase IIIb clinical 71 SNT MC# 71 forodesine 71 THALOMID 71 subcutaneous formulation 71 TORISEL 71 SPRYCEL ® 71 Phase Ib clinical 71 Fibrillex TM 71 dirucotide 71 Phase IIa trials 71 oxymorphone ER 71 Phase Ib study 71 Cimzia ® certolizumab pegol 71 Androxal TM 71 methylnaltrexone 71 FOLOTYN ® 71 Torisel 71 TEMODAL 70 BRIM2 70 alvimopan 70 phase IIb trial 70 Amrubicin 70 PROMACTA 70 Fx #A 70 Tarceva TM 70 phase IIa clinical 70 Raptiva R 70 herpetic keratitis 70 brivaracetam 70 neratinib 70 Fludara 70 confirmatory Phase III 70 LEUKINE 70 MAA submission 70 TBC# 70 Romiplostim 70 Cloretazine R VNP#M 70 Saforis 70 JAK inhibitor 70 Evoltra ® 70 lumiliximab 70 Targretin capsules 70 Traficet EN 70 GSK# [001] 70 Aryplase 70 Pemetrexed 70 ORENCIA ® 69 romiplostim 69 Evoltra 69 IL# PE#QQR 69 randomized controlled Phase 69 oral ridaforolimus 69 LymphoStat B TM 69 SUTENT 69 Vidaza azacitidine 69 pharmacokinetic PK study 69 Cloretazine 69 SUTENT ® 69 ocrelizumab 69 efalizumab 69 PEG SN# 69 Dacogen TM 69 IV Busulfex 69 IMA# 69 HuMax EGFr 69 Cloretazine ® 69 rilonacept 69 Phase III randomized controlled 69 alvespimycin 69 Allovectin 7 69 Panzem R NCD 69 phase IIb 69 UPLYSO 69 vandetanib 69 multicenter Phase 69 refractory CLL 69 teduglutide 69 UVIDEM 69 Annamycin 69 placebo controlled Phase 69 TELCYTA 69 docetaxel Taxotere ® 69 Phase Ib II 69 Onco TCS 69 ONTAK 69 OHR/AVR# 69 Alocrest 69 Proellex TM 69 Hycamtin 69 OncoVEX GM CSF 69 Soliris TM eculizumab 69 Phase #b/#a 69 TYKERB 69 Cimzia TM 69 Pivotal Phase III 69 PrevOnco 69 ELACYT 69 hoFH 69 CEQ# 69 refractory chronic lymphocytic 69 riociguat 69 enzastaurin 69 BEXXAR 69 ZACTIMA 69 decitabine 69 Ceflatonin R 69 budesonide foam 68 acute HAE attacks 68 G#DT 68 Xyrem ® 68 Phase Ib 68 glatiramer acetate 68 Gleevec Glivec 68 including eniluracil ADH 68 GAMMAGARD 68 multicenter Phase II 68 RAPTIVA 68 GW# [003] 68 dirucotide MBP# 68 Neulasta ® 68 acyclovir Lauriad R 68 PREOS R 68 Angiox ® 68 Azedra 68 lintuzumab SGN 68 tesmilifene 68 PXD# 68 HCD# [002] 68 EOquin TM 68 CHAMPION PCI 68 Navelbine ® 68 elacytarabine 68 celgosivir 68 Phase #/#a trial 68 generation purine nucleoside 68 reslizumab 68 axitinib 68 tramiprosate Alzhemed TM 68 BrachySil TM 68 eltrombopag 68 GATTEX TM 68 sodium thiosulfate STS 68 Evoltra R 68 AZILECT ® 68 Pimavanserin 68 tolevamer 68 ixabepilone 68 NP2 Enkephalin 68 Taxotere ® 68 opioid induced bowel dysfunction 68 Allovectin 7 ® 68 low dose cytarabine 68 PrevOnco ™ 68 Canvaxin 68 blinatumomab 68 evaluating REVLIMID 68 vidofludimus 68 valopicitabine 68 phase IIa 68 Aflibercept 68 IRESSA 68 phase III isavuconazole 68 Dacogen 68 tanespimycin 68 relapsed multiple myeloma 68 CIMZIA TM 68 investigational monoclonal antibody 68 ONGLYZA ™ 68 CLARITY study 68 phase Ib 68 catheter occlusion 68 TYZEKA 68 SinuNase 68 Tasigna nilotinib 68 seliciclib CYC# 68 glufosfamide 68 rALLy clinical trial 68 Pirfenidone 68 Phase IIb III 68 Phase #/#a 68 amrubicin 68 Phase 1b clinical 68 antibody MAb 68 Vandetanib 68 relapsed MM 68 Phase 2b study 68 Octreolin 68 multiple myeloma MM 68 pomalidomide 68 BENLYSTA ® 68 posaconazole 68 Increlex R 68 Epratuzumab 68 Noxafil 68 CAELYX 68 nalbuphine ER 68 LUX Lung 67 TACI Ig 67 RhuDex ® 67 BLA filing 67 Rescula 67 FOLOTYN 67 PEG interferon 67 zanolimumab 67 Bicifadine 67 refractory gout 67 Gleevec imatinib mesylate 67 SYCREST 67 Nuvion 67 OZURDEX ® 67 Virulizin R 67 dose escalation clinical 67 MAGE A3 ASCI 67 Temsirolimus 67 EOquin 67 Taxotere docetaxel 67 Advagraf 67 induced macular edema 67 aflibercept VEGF Trap 67 HQK 67 adult chronic ITP 67 icatibant 67 YERVOY 67 MNTX 67 Proquin XR 67 miconazole Lauriad ® 67 Phase IIb trials 67 Increlex ® 67 urocortin 2 67 IRX 2 67 Vernakalant 67 oral prodrug 67 Proxinium TM 67 incyclinide 67 adalimumab Humira 67 Loramyc R 67 palonosetron 67 KNS # 67 PDX pralatrexate 67 EndoTAG TM -1 67 Mylotarg 67 GALNS 67 investigational compounds 67 Dalbavancin 67 aflibercept 67 Vimpat ® lacosamide 67 balsalazide tablet 67 cilengitide 67 ATL# [001] 67 Clevudine 67 rALLy 67 R sorafenib tablets 67 Revlimid lenalidomide 67 ZOLINZA 67 azacitidine 67 trabectedin 67 trastuzumab DM1 T DM1 67 Alzhemed TM 67 eculizumab 67 terlipressin 67 Zenvia Phase III 67 visilizumab 67 Rebif ® 67 NEBIDO 67 Xelox 67 ISTODAX 67 galiximab 67 BLA submission 67 Asentar 67 midstage clinical 67 Tanespimycin 67 desvenlafaxine 67 Civacir 67 torezolid phosphate 67 Clofarabine 67 CDP# 67 docetaxel Taxotere R 67 biologic DMARD 67 Neuradiab 67 TYGACIL 67 methylnaltrexone bromide 67 NUVIGIL 67 sorafenib tablets 67 relapsing multiple sclerosis 67 esophageal candidiasis 67 apricitabine 67 placebo controlled Phase III 67 Peginterferon alfa 2b 67 treatment naive genotype 67 CytoFab 67 ONCASPAR 67 telomerase therapeutic 67 XL# SAR# 67 L BLP# 67 Onrigin 67 DEB# 67 Irinotecan 67 Aviptadil 67 albinterferon alfa 2b 67 LAF# 67 COMFORT II 67 AZX# 67 Virulizin ® 67 Xanafide 67 Phase Ib IIa 67 Nexavar sorafenib 67 recurrent glioblastoma multiforme 67 vinorelbine tartrate 67 MKC# MT 67 AZILECT R 67 phase IIIb 67 Gattex 67 Certolizumab pegol 67 panitumumab Vectibix 67 Aplidin 67 REMINYL ® 67 Zenvia ™ 67 oral methylnaltrexone 67 MERLIN TIMI 67 BRIM3 67 romidepsin 67 Mepact 67 Genasense ® 67 Zarnestra 67 Frova ® 67 clofarabine 67 CIMZIA ™ 67 Golimumab 67 crizotinib PF # 67 Firazyr 67 Arcalyst 67 Phase IIa trial 67 Plenaxis R 67 receptor tyrosine kinase inhibitor 67 Catena ® 67 Voraxaze ™ 67 tramiprosate ALZHEMED TM 67 dacetuzumab 67 dose escalation phase 67 novel VDA molecule 67 indiplon capsules 67 severe hypercholesterolemia 67 Neupogen ® 67 Arzerra ofatumumab 67 Epirubicin 67 ORENCIA R 67 TLK# 67 fostamatinib 67 Topotecan 67 AzaSite Plus 67 MAXY alpha 67 Phase III psoriasis 67 Theratope 67 Certolizumab 67 etanercept Enbrel 67 Aloxi injection 67 Cetrorelix 67 Phase 1a clinical 67 Corlux 67 Junovan 67 VPRIV 67 relapsing remitting MS RRMS 67 Soliris eculizumab 67 Myocet 67 refractory APL 67 telaprevir VX 67 desvenlafaxine succinate 67 non metastatic osteosarcoma 67 alpha 2a 67 Kepivance 67 Targretin 67 histamine dihydrochloride 67 APPRAISE 66 alemtuzumab Campath 66 PEG INTRON R 66 Sprycel dasatinib 66 SUCCEED trial 66 Glufosfamide 66 randomized multicenter Phase III 66 Cethrin 66 acyclovir Lauriad ® 66 sorafenib Nexavar 66 Phenoptin 66 Archexin 66 MGd 66 Shigamabs ® 66 blinded randomized placebo controlled 66 eosinophilic asthma 66 Campath ® 66 #I TM# 66 DAVANAT 66 atacicept 66 TRISENOX ® 66 ancrod 66 Phase 2b clinical 66 teriflunomide 66 Eloxatin ® 66 Spiegelmer ® 66 ALGRX 66 phase IIb III 66 BAY #-# 66 Ocrelizumab 66 dimebon 66 Preotact 66 Bezielle 66 Luteinizing Hormone Releasing Hormone 66 Actimmune R 66 Deferiprone 66 Phase III clinical 66 registrational trial 66 docetaxel Taxotere 66 Enzyme Replacement Therapy 66 EDEMA3 66 Marketing Authorisation Application 66 BRILINTA 66 pediatric acute lymphoblastic 66 RhuDex 66 REVLIMID R 66 drug ISA# 66 Fabry Disease 66 registrational 66 GOUT 66 REPLAGAL 66 Exherin TM 66 octreotide implant 66 Hedgehog antagonist 66 daclizumab 66 Phase 2a trial 66 Quinamed 66 diarrhea predominant irritable 66 sargramostim 66 RSD# oral 66 Tarceva erlotinib 66 JZP 66 Aptivus ® 66 samalizumab 66 randomized Phase IIb 66 SinuNase ™ 66 cannabinor 66 Ketotransdel 66 Neulasta R 66 pediatric Crohn disease 66 FavId 66 ofatumumab 66 Pafuramidine 66 Vfend 66 calcineurin inhibitor 66 Phase IIa clinical trials 66 Certican 66 omacetaxine mepesuccinate 66 Arranon 66 Pegintron 66 pradefovir 66 Jevtana 66 placebo controlled clinical 66 prokinetic agent 66 OPAXIO 66 figitumumab 66 ADVANCE PD 66 PSMA ADC 66 rotigotine transdermal patch 66 Fodosine 66 bardoxolone 66 Removab 66 Acute Radiation Syndrome ARS 66 calcineurin inhibitors 66 CUSTOM III 66 FASLODEX 66 CALGB # [002] 66 TREANDA 66 Natalizumab 66 Kamada AAT 66 TASKi3 66 Interferon beta 1a 66 Phase IIB 66 ACZ# 66 ASA# 66 Avastin bevacizumab 66 Dual Opioid 66 bazedoxifene 66 Augment Injectable 66 bevacizumab Avastin 66 Azedra TM 66 Afatinib 66 Phase IIIb 66 Pertuzumab 66 HepeX B TM 66 NOXAFIL 66 Rhucin R 66 recurrent GBM 66 INSPIRE Trial Phase III 66 volociximab 66 oral rivaroxaban 66 Specifid 66 Levoleucovorin 66 ISENTRESS 66 ARCALYST 66 Phase 2b kidney transplant 66 Vitaxin 66 Oncaspar 66 eprodisate Fibrillex TM 66 sNDA filing 66 HCV SPRINT 66 Bayer Onyx 66 PRISTIQ 66 IMiDs 66 Personalized Immunotherapy 66 pegylated interferon alpha 66 Nebido 66 Motavizumab 66 ATryn R 66 Marketing Authorisation Application MAA 66 BCIRG 66 rindopepimut 66 oral deforolimus 66 dalbavancin 66 BeneFIX 66 gefitinib Iressa 66 deforolimus 66 Microplasmin 66 Aurexis 66 Sutent sunitinib 66 ANTEGREN 66 ecallantide 66 ruxolitinib 66 MYCAMINE 66 Mycamine 66 Onalta ™ 66 Zavesca 66 Sym# 66 pitavastatin 66 Neupro R 66 Betaferon ® 66 KRN# 66 eprotirome 66 fosbretabulin 66 Cellegesic 66 Degarelix 66 Zenapax 66 6R BH4 66 SCENESSE ® 66 thalidomide Thalomid 66 obatoclax 66 palifosfamide 66 Pegloticase 66 Folotyn 66 Humira adalimumab 66 SUPPRELIN R LA 66 Icatibant 66 ganetespib 66 Betaferon R 66 Ilaris 66 CIMZIA TM certolizumab pegol 66 mRCC 66 Known hypersensitivity 66 cediranib 66 vosaroxin 66 invasive candidiasis 66 baminercept 66 Nabi HB Intravenous 66 Proleukin 66 EXPAREL ™ 66 Thalomid ® 66 Elitek 66 AVONEX ® 66 Phase #b/#a clinical 66 ponatinib 66 relapsed refractory multiple myeloma 66 pain palliation 66 tremelimumab 66 Teysuno 66 motavizumab 66 EGS# 66 EFAPROXYN 66 ezogabine 66 DepoDur 66 CHMP recommendation 66 Hepatocellular Carcinoma HCC 66 ARIXTRA R 66 INTERCEPT platelets 66 Angiox R 66 Vectibix panitumumab 66 RoACTEMRA 66 Mipomersen 66 ILUVIEN ® 66 mertansine 66 Phase 1b clinical trials 66 phase Ib clinical 66 Pazopanib 66 dexanabinol 66 ATryn ® 66 R roscovitine 66 AMEVIVE 66 CONBRIZA 66 CAMPATH 65 diabetic neuropathic pain 65 ketolide antibiotic 65 tigecycline 65 Ophena TM 65 Egrifta 65 REVLIMID ® 65 cintredekin besudotox 65 custirsen 65 mifamurtide 65 ITAX 65 SYMMETRY trial 65 multicenter Phase III 65 rALLy trial 65 ALN PCS 65 sNDA submission 65 Randomized Phase 65 PROSTVAC ® 65 dorzolamide 65 octreotide acetate 65 canakinumab 65 velafermin 65 ribavirin RBV 65 severe gastroparesis 65 pertuzumab 65 gemcitabine Gemzar ® 65 HGS# 65 paclitaxel Taxol ® 65 elesclomol 65 vismodegib 65 Glatiramer Acetate 65 Ozarelix 65 Prostate AdenoCarcinoma Treatment 65 Treanda 65 LEVADEX ™ 65 eniluracil 65 PEGINTRON TM 65 leading oral taxane 65 Pivotal Phase 65 Troxatyl TM 65 Aplidin R 65 acetonide FA 65 INCB# [001] 65 Pixuvri 65 Gliadel Wafer 65 PRT# 65 Besivance 65 REMICADE ® 65 GVAX 65 zileuton CR 65 vinorelbine 65 REVLIMID lenalidomide 65 Phase 2b trial 65 Fludara ® 65 PNT# 65 Inhalation Solution 65 oral Azacitidine 65 RSR# 65 Eculizumab 65 Phase Ib clinical trials 65 liposomal formulation 65 PANVAC VF 65 iniparib 65 Trobalt 65 plus prednisone 65 cutaneous T 65 Insegia 65 novel oral anticoagulant 65 CTAP# Capsules 65 Arixtra 65 Safinamide 65 PRECiSE 65 plus DOXIL 65 Phase 1b 65 PROVENGE sipuleucel T 65 metastatic RCC 65 Zavesca R 65 assessing T DM1 65 Levetiracetam 65 metaglidasen 65 Twinrix 65 alfa 2a 65 TheraCIM 65 Huntexil 65 Behcet uveitis 65 Neurodex 65 regorafenib 65 dasatinib Sprycel ® 65 dose escalation trial 65 palifermin 65 OvaRex R 65 GLP toxicology studies 65 Oxaliplatin 65 IV acetaminophen 65 phase IIb study 65 AeroLEF TM 65 Viramidine 65 PD LID 65 Campath alemtuzumab 65 Marqibo 65 bicifadine 65 MGCD# [001] 65 LymphoStat B 65 BrachySil 65 REYATAZ R 65 ROTATEQ 65 Sycrest 65 Entereg R 65 vapreotide acetate 65 placebo controlled clinical trials 65 intravenous methylnaltrexone 65 ritonavir boosted danoprevir 65 ridaforolimus 65 Drug Eluting Stent System 65 Tamibarotene 65 MACUGEN 65 Retisert TM 65 EVICEL 65 BST CarGel R 65 Cethrin R 65 comparator arm 65 Feraheme ® 65 VEGF Trap 65 Copegus ribavirin 65 mycophenolate mofetil 65 APTIVUS 65 TroVax 65 Hedgehog Pathway Inhibitor 65 miconazole MBT 65 hypomethylating agents 65 cinacalcet HCl 65 ALVESCO R 65 Cancidas 65 iclaprim 65 ARCOXIA 65 GED aPC 65 MoxDuo IR 65 LUNESTA TM 65 HDAC Inhibitor 65 lomitapide 65 Vidaza 65 docetaxel chemotherapy 65 rasagiline tablets 65 daptomycin 65 IoGen 65 RITUXAN 65 Capesaris 65 Clolar 65 velaglucerase alfa 65 VELCADE melphalan 65 Diamyd ® 65 Iluvien ® 65 erlotinib Tarceva ® 65 paclitaxel Taxol 65 Dasatinib 65 Urocidin TM 65 Altastaph 65 Orphan Status 65 TroVax ® 65 GRNVAC1 65 Plenaxis TM 65 nab paclitaxel 65 Phase III Pivotal 65 Nimotuzumab 65 Calcium Acetate 65 AEG# 65 Cx# [002] 65 GEM OS1 65 Orapred ODT 65 DASISION 65 PROSTVAC TM 65 dextromethorphan quinidine 65 REBETOL combination therapy 65 Alvesco R 65 refractory metastatic colorectal cancer 65 Prosaptide 65 nonclinical studies 65 squalamine 65 Hematide TM 65 Kit CD# positive 65 FOR FURTHER INFORMATION ABOUT 65 HuMax TAC 65 CANCIDAS 65 Xcytrin R 65 Telintra 65 Teflaro 65 Yondelis ® 65 Stimuvax R 65 CRMD# 65 NATRECOR ® 65 PLAVIX ® 65 TRANSDUR Sufentanil 65 glatiramer 65 MyVax R 65 Alemtuzumab 65 rNAPc2 65 gastrointestinal disorders ATI 65 anthracyclines taxanes 65 huN# DM1 65 Ceflatonin 65 recurrent glioma 65 Phase IIa clinical 65 Cimzia ® 65 LymphoStat B belimumab 65 Dapagliflozin 65 Tectin TM 65 novel emulsion formulation 65 PEG PAL 65 Angiox 65 orBec 65 HGS ETR1 65 opioid induced constipation OIC 65 PREOS 65 chemotherapy induced neutropenia 65 Bazedoxifene 65 FDA Approvable Letter 65 clinical pharmacology studies 65 MOZOBIL 65 Keppra XR 65 MDS AML 65 Elagolix 65 Cimzia certolizumab pegol 65 Trovax 65 sunitinib 65 tosedostat 65 NXL# 65 PEGylated interferon beta 1a 65 boosted protease inhibitor 65 BR.# 65 ToGA 65 Voraxaze 65 intravenous acetaminophen 65 HepeX B 65 IIa trial 65 ICA # 65 Cleviprex TM clevidipine 65 metastatic CRC 65 nosocomial pneumonia 65 HspE7 65 Kynapid 65 AZD# TC 65 Fast Track Status 65 tocilizumab 65 Vidaza R 65 lorvotuzumab mertansine 65 VNP#M 65 Evoltra TM 65 STRIDE PD 65 clobazam 65 abiraterone acetate 65 Phase III Clinical Trial 65 Argatroban 65 RH1 65 olanzapine LAI 65 IMPACT IMmunotherapy 65 lintuzumab 65 Pivotal Study 65 intranasal formulation 65 Eligard ® 65 Rapaflo 65 Nexavar ® 65 painful diabetic neuropathy 65 torsemide ER 65 Sanctura XR 65 cisplatin gemcitabine 65 casopitant 65 Navelbine R 65 LUMINATE 65 BYDUREON 65 ofatumumab HuMax CD# 65 pegylated interferon alfa 2b 65 Mycograb 65 Zingo TM 65 HBeAg positive patients 64 E1 INT TM 64 rhThrombin 64 huC# DM4 64 miglustat 64 otelixizumab 64 Retacrit 64 Lu AA# 64 MabCampath 64 lexidronam injection 64 VALSTAR 64 Azilect ® 64 Ozurdex 64 eculizumab therapy 64 metastatic malignant 64 vicriviroc 64 PROCRIT ® 64 apaziquone 64 Genasense 64 Loramyc 64 mitoxantrone plus 64 THALOMID R 64 HuLuc# 64 omecamtiv mecarbil 64 lucinactant 64 Cinquil 64 TAXUS TM 64 orphan designation 64 ARCALYST ® 64 Celgene Revlimid 64 thymalfasin 64 CHOP chemotherapy 64 Vascular Wrap TM 64 Tasimelteon 64 VFEND 64 ALN HPN 64 Acute Ischemic Stroke 64 Ixabepilone 64 Dyloject TM 64 INTELENCE 64 active comparator 64 Prestara 64 AEterna 64 Sanvar R 64 sapacitabine CYC# 64 Phase III clinical trials 64 standard chemotherapy regimen 64 CD# CEA 64 Pegylated Interferon 64 ACTEMRA 64 Surfaxin LS 64 OvaRex MAb 64 histone deacetylase HDAC inhibitor 64 resminostat 64 senicapoc 64 MKC# MKC# PP 64 Ticagrelor 64 CRLX# 64 midstage trials 64 AZASITE 64 Forodesine HCl 64 rFVIIa 64 ATACAND 64 Zenpep 64 SAR# [004] 64 Serdolect ® 64 Aurograb 64 LHRH antagonist 64 Urocidin 64 LEP ETU 64 HoFH 64 Somatuline R Depot 64 COLAZAL R 64 Pentacel vaccine 64 dosing cohort 64 Triapine R 64 Hyphanox 64 malignant ascites 64 TheraSphere 64 Canvaxin TM 64 HCV RESPOND 2 64 Chrysalin 64 Testosterone MDTS ® 64 Zorbtive TM 64 Ecallantide 64 Naglazyme 64 IV APAP 64 ® natalizumab 64 preclinical efficacy 64 ACOMPLIA R 64 Remicade infliximab 64 SomatoKine 64 Joulferon 64 ADVEXIN clinical 64 Atrasentan 64 Genasense ® oblimersen 64 PEG INTRON 64 clevudine 64 Extina 64 BCX# 64 INCB# [002] 64 r hGH 64 Loramyc ® 64 Onconase 64 Tezampanel 64 Auxilium Pharma 64 Ophena 64 YONDELIS R 64 POSIDUR TM 64 unique alkylating agent